| Serial Number | 90722349 |
| Word Mark | COBALT |
| Filing Date | Wednesday, May 19, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, May 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 22, 2022 |
| Goods and Services | Cells for medical or clinical use; Pharmaceutical preparations being pharmaceutical and biopharmaceutical agents for the treatment of cancer; gene therapy products, namely, pharmaceutical preparations being gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer |
| Goods and Services | Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 17, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 17, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Crispr Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 CH-6300 CH |
| Party Name | Crispr Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 CH-6300 CH |
| Event Date | Event Description |
| Saturday, May 22, 2021 | NEW APPLICATION ENTERED |
| Tuesday, August 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 11, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, January 19, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 19, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 19, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 19, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 19, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 22, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, October 3, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 3, 2022 | SOU EXTENSION 1 FILED |
| Monday, October 3, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, October 5, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, March 15, 2023 | SOU EXTENSION 2 FILED |
| Wednesday, March 15, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, March 17, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 28, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 28, 2023 | SOU EXTENSION 3 FILED |
| Monday, August 28, 2023 | SOU EXTENSION 3 GRANTED |
| Wednesday, August 30, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, May 20, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, May 20, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |